Filter
704
Filtered Results: 704
Text search:
Drug
Prevention
and
Information
Programme
of
the
European
Union
Featured
Recommendations
53
New Publications
150
Language
Document type
No document type
419
Studies & Reports
146
Guidelines
65
Manuals
32
Strategic & Response Plan
23
Fact sheets
9
Situation Updates
5
Training Material
4
Resource Platforms
1
Countries / Regions
Western and Central Europe
75
Eastern Europe
29
Global
26
Sierra Leone
18
Myanmar / Burma
16
Ukraine
15
India
12
Zambia
12
Africa
12
Liberia
11
Kenya
11
Uganda
8
Nigeria
7
Bangladesh
7
Malawi
7
Eastern Europe and Central Asia
7
Lesotho
6
Tajikistan
6
Senegal
5
Ethiopia
5
South Africa
5
Latin America and the Carribbean
5
Guinea
4
Ghana
4
Philippines
4
Nepal
4
Tanzania
4
Cambodia
4
Rwanda
4
Namibia
4
Eswatini/ Swaziland
4
Middle East and North Africa
4
Asia
4
Russia
4
Thailand
3
Botswana
3
West and Central Africa
3
Albania
3
Laos
3
Moldova
3
Georgia
3
Burkina Faso
2
Zimbabwe
2
South Sudan
2
Germany
2
North Macedonia
2
East and Southern Africa
2
Vietnam
2
Congo, Democratic Republic of
1
USA
1
Somalia
1
Pakistan
1
Iraq
1
Afghanistan
1
Turkey
1
Syria
1
Indonesia
1
Ireland
1
Sudan
1
Benin
1
Brazil
1
Serbia
1
El Salvador
1
Sri Lanka
1
South–East Asia Region
1
Western Pacific Region
1
Bhutan
1
Venezuela
1
Poland
1
Armenia
1
Bulgaria
1
Estonia
1
Romania
1
Lithuania
1
Uzbekistan
1
Kazakhstan
1
Turkmenistan
1
Denmark
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
173
Clinical Guidelines
57
Public Health
46
Pharmacy & Technologies
19
Key Resources
13
Women & Child Health
10
Capacity Building
5
Toolboxes
HIV
117
TB
117
Mental Health
90
AMR
60
COVID-19
26
Pharmacy
23
Rapid Response
19
Refugee
15
Planetary Health
14
NCDs
14
Ebola
13
Global Health Education
10
Disability
9
Conflict
9
Caregiver
7
NTDs
7
Health Financing Toolbox
7
Polio
3
Natural Hazards
2
Cholera
1
Zika
1
Specific Hazards
1
Social Ethics
1
Health Financing
1
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutica...
While there has been real progress in addressing the burden of disease in the WHO African region, the...
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health ... sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obstacles to achieving better health outcomes and better standards of living worldwide. Using a cultural contexts of health approach, the policy brief explores the centrality of culture to the challenge of ABR. The brief examines how the prescription and use of antibacterial medicines, the transmission of resistance, and the regulation and funding of research are influenced by cultural, social and commercial, as well as biological and technological factors. The brief moves beyond the ready equation of culture with individual behaviours and demonstrates how culture serve as an enabler of health and provide new possibilities for change.
The main objectives of these guidelines are to:
1. contribute to the quality assurance of m...
1. contribute to the quality assurance of m...
This 10th edition of the Institute for Health Metrics and Evaluation’s annual Financing Global Health report provides ... most up-to-date estimates of development assistance for health, domestic spending on health, health spending on two key infectious diseases – malaria and HIV/AIDS – and future scenarios of health spending. Several transitions in global health financing inform this report: the influence of economic development on the composition of health spending; the emergence of other sources of development assistance funds and initiatives; and the increased availability of disease-specific funding data for the global health community. For funders and policymakers with sights on achieving 2030 global health goals, these estimates are of critical importance. They can be used for identifying funding gaps, evaluating the allocation of scarce resources, and comparing funding across time and countries.
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively...
Universal health coverage and the Sustainable Development Goals in the WHO African Region
2016-2018 Early implementation,
This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributin...
Good mental health is integral to human health and well being. A person’s mental health and many common mental disorders are shaped by various social, economic, ... physical environments operating at different stages of life. Risk factors for many common mental disorders are heavily associated with social inequalities, whereby the greater the inequality the higher the inequality in risk.
The present booklet is about gender-responsive substance abuse treatment services for women. It is part of the United Nations Office on Drugs ... Crime (UNODC) project to develop tools to support the development and improvement of substance abuse treatment services, based on evidence from the literature and case studies that illustrate practical experiences and lessons learned in providing substance abuse treatment services in various regions of the world.
arrow country studies
Political developments in Myanmar/Burma prompted the Asian-Pacific Resource and Research Centre for Women (ARROW) in 2013 to undertake a small-scale scoping study to re-eval...
Political developments in Myanmar/Burma prompted the Asian-Pacific Resource and Research Centre for Women (ARROW) in 2013 to undertake a small-scale scoping study to re-eval...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited...
This report makes clear that there is a path to end AIDS. Taking that path will help ensure preparedness to address other pandemic challenges, and advance progress across the Sustainable Development...
Updated version – September 2020
The COVID-19 pandemic is affecting everyone. Globally, millions of people have been infected with the virus, wh...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of ...
This report challenges policy-makers and political leaders to tackle fossil fuel production and consumption as a health control issue, in the same ...
Ramped-up cancer services could save 7 million lives over the next decade—and addressing huge service gaps between rich and poor countries is key...
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on ... WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve the effectiveness of medically important antimicrobials, particularly those antimicrobials judged to be critically important to human medicine and also help preserve the effectiveness of antimicrobials for veterinary medicine, in direct support of the WHO global action plan on antimicrobial resistance
Available in Arabic, Chinese, English, French, Russian and Spanish. You can download a summary of the main report ... background documents!
The report demonstrates that the current system—at both national and international levels— was not adequate to protect people from COVID-19. The time it took from the reporting of a cluster of cases of pneumonia of unknown origin in mid-late December 2019 to a Public Health Emergency of International Concern being declared was too long. February 2020 was also a lost month when many more countries could have taken steps to contain the spread of SARS-CoV-2 and forestall the global health, social, and economic catastrophe that continues its grip. The Panel finds that the system as it stands now is clearly unfit to prevent another novel and highly infectious pathogen, which could emerge at any time, from developing into a pandemic.
2nd edition. The 2018 Roadmap incorporates an additional critical population: adolescents. Despite making up 1 in 6 of the world’s people, adoles...
